2. PBPK Modeling to Simulate the Fate of Compounds in Living Organisms
Frédéric Y. Bois, Cleo Tebby, and Céline Brochot
3. Pharmacokinetic Tools and Applications
Judith C. Madden and Courtney V. Thompson
4. In Silico Tools and Software to Predict ADMET of New Drug Candidates
Supratik Kar, Kunal Roy, and Jerzy Leszczynski
Part II: Exploiting Toxicity Data for Modeling Purposes
5. Development of In Silico Methods for Toxicity Prediction in Collaboration between Academia and the Pharmaceutical Industry
Manuel Pastor, Ferran Sanz, and Frank Bringezu
6. Emerging Bioinformatics Methods and Resources in Drug Toxicology
Karine Audouze and Olivier Taboureau
Part III: The Use of In Silico Models for the Specific Endpoints
7. In Silico Prediction of Chemically-Induced Mutagenicity: A Weight of Evidence Approach Integrating Information from QSAR Models and Read-Across Predictions
Enrico Mombelli, Giuseppa Raitano, and Emilio Benfenati
8. In Silico Methods for Chromosome Damage
Diego Baderna, Ilse Van Overmeire, Giovanna J. Lavado, Domenico Gadaleta, and Birgit Mertens
9. In Silico Methods for Carcinogenicity Assessment
Azadi Golbamaki, Emilio Benfenati, and Alessandra Roncaglioni
10. In Silico Models for Developmental Toxicity
Marco Marzo, Alessandra Roncaglioni, Sunil Kulkarni, Tara S. Barton-Maclaren, and Emilio Benfenati
11. In Silico Models for Repeated-Dose Toxicity (RDT): Prediction of the No Observed Adverse Effect Level (NOAEL) and Lowest Observed Adverse Effect Level (LOAEL) for Drugs
Fabiola Pizzo, Domenico Gadaleta, and Emilio Benfenati
12. In Silico Models for Predicting Acute Systemic Toxicity
Ivanka Tsakovska, Antonia Diukendjieva, and Andrew P. Worth
13. In Silico Models for Skin Sensitization and Irritation
Gianluca Selvestrel, Federica Robino, and Matteo Zanotti Russo
14. In Silico Models for Hepatotoxicity
Claire Ellison, Mark Hewitt, and Katarzyna Przybylak
15. Machine Learning Models for Predicting Liver Toxicity
Jie Liu, Wenjing Guo, Sugunadevi Sakkiah, Zuowei Ji, Gokhan Yavas, Wen Zou, Minjun Chen, Weida Tong, Tucker A Patterson, and Huixiao Hong
Part IV: Platforms for Evaluating Pharmaceuticals
16. Implementation of In Silico Toxicology Protocols in Leadscope
Kevin Cross, Candice Johnson, and Glenn J. Myatt
17. Use of Lhasa Limited Products for the In Silico Prediction of Drug Toxicity
David J. Ponting, Michael J. Burns, Robert S. Foster, Rachel Hemingway, Grace Kocks, Donna S. Macmillan, Andrew L. Shannon-Little, Rachael E. Tennant, Jessica R. Tidmarsh, and David J. Yeo
18. Using VEGAHUB within a Weight-of-Evidence Strategy
Serena Manganelli, Alessio Gamba, Erika Colombo, and Emilio Benfenati
19. MultiCASE Platform for In Silico Toxicology
Suman K. Chakravarti and Roustem D. Saiakhov
Part V: The Scientific and Society Challenges
20. Adverse Outcome Pathways as Versatile Tools in Liver Toxicity Testing
Emma Gustafson, Eva Gijbels, Bruna dos Santos Rodrigues, Vânia Vilas-Boas, and Mathieu Vinken
21. The Use of In Silico Methods for the Regulatory Toxicological Assessment of Pharmaceutical Impurities
Simona Kovarich and Claudia Ileana Cappelli
22. Computational Modeling of Mixture Toxicity
Mainak Chatterjee and Kunal Roy
23. In SilicoMethods for Ecological Risk Assessment: Principles, Tiered Approaches, Applications, and Future Perspectives
Maria Chiara Astuto, Matteo R. Di Nicola, José V. Tarazona, Yann Devos, Djien A.K. Liem, George E.N. Kass, Maria Bastaki, Reinhilde Schoonjans, Angelo Maggiore, Sandrine Charles, Aude Ratier, Christelle Lopes, Ophelia Gestin, Tobin Robinson, Anthony Williams, Nynke Kramer, Edoardo Carnesecchi, and Jean-Lou C.M. Dorne
24. Increasing the Value of Data within a Large Pharmaceutical Company through In Silico Models
Alessandro Brigo, Doha Naga, and Wolfgang Muster
This fully updated book explores all-new and revised protocols involving the use of in silico models, particularly with regard to pharmaceuticals. Divided into five sections, the volume covers the modeling of pharmaceuticals in the body, toxicity data for modeling purposes, in silico models for multiple endpoints, a number of platforms for evaluating pharmaceuticals, as well as an exploration of challenges, both scientific and sociological. Written for the highly successful Methods in Molecular Biology series, chapters include the kind of detail and implementation advice necessary for successful results.
Authoritative and comprehensive, In Silico Methods for Predicting Drug Toxicity, Second Edition aims to guide the reader through the correct procedures needed to harness in silico models, a field which now touches a wide variety of research specialties.